SEC Form 4 · accession 0001213900-15-009522
RELMADA THERAPEUTICS, INC. · RLMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul Edward Kelly
Director
Period of report
Dec 14, 2015
Accepted (ET)
Dec 16, 2015 · 4:27 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001553643
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock | Dec 14, 2015 | P | 3,000 | $3.00 | A | 3,000 | D | |
| Common stock | Dec 14, 2015 | P | 1,500 | $2.97 | A | 4,500 | D | |
| Common stock | Dec 14, 2015 | P | 500 | $2.98 | A | 5,000 | D | |
| Common stock | Dec 14, 2015 | P | 3,000 | $2.89 | A | 8,000 | D | |
| Common stock | Dec 14, 2015 | P | 1,400 | $2.90 | A | 9,400 | D | |
| Common stock | Dec 14, 2015 | P | 600 | $2.30 | A | 10,000 | D |
Table II — derivative securities
No Table II lines on this filing.